Joseph J Sacco

11PUBLICATIONS
76CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersTissue engineeringNgā kaiwhakawhānau me te mātai mate tamariki o te Māori (Māori midwifery and paediatrics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.

Takami Sato, Marcus O Butler, Sophie Piperno-Neumann

|Jul 08, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Michael K Wong, Mohammed M Milhem, Joseph J Sacco

|Jun 26, 2025
Methodology for generating chorioallantoic membrane patient-derived xenograft (CAM-PDX) models of pleural mesothelioma and performing preclinical imaging for the translation of cancer studies and drug screening.

Jan Schulze, Sarah Barnett, Liam Shaw

|Mar 11, 2025
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer.

Esra Güç, Agatha Treveil, Emma Leach

|Oct 10, 2024
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.

Rino S Seedor, Andrew E Aplin, Corine Bertolotto

|Jun 06, 2024
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.

Joseph J Sacco, Richard D Carvajal, Marcus O Butler

Pageof 2

Frequent Collaborators

3 joint publications

Mark R Middleton

3 joint publications

Richard D Carvajal

3 joint publications

Marcus O Butler

3 joint publications

Takami Sato